Maternal DHA Supplementation during Pregnancy and Lactation in the Rat Protects the Offspring against High-Calorie Diet-Induced Hepatic Steatosis
Authors:
- Amran Daher-AbdiADAmran Daher-Abdi
- Sandra Olvera HernándezSHSandra Olvera Hernández
- Luis Antonio Reyes CastroLCLuis Antonio Reyes Castro
- Carla Elena Mezo-GonzálezCMCarla Elena Mezo-González
- Mikaël CroyalMCMikaël Croyal
- Juan Antonio García-SantillánJGJuan Antonio García-Santillán
- Khadija OuguerramKOKhadija Ouguerram
- Elena ZambranoEZElena Zambrano
- Francisco Bolaños-JiménezFBFrancisco Bolaños-Jiménez
Open Access
Abstract
Maternal supplementation during pregnancy with docosahexaenoic acid (DHA) is internationally recommended to avoid postpartum maternal depression in the mother and improve cognitive and neurological outcomes in the offspring. This study was aimed at determining whether this nutritional intervention, in the rat, protects the offspring against the development of obesity and its associated metabolic disorders. Pregnant Wistar rats received an extract of fish oil enriched in DHA or saline (SAL) as placebo by mouth from the beginning of gestation to the end of lactation. At weaning, pups were fed standard chow or a free-choice, high-fat, high-sugar (fc-HFHS) diet. Compared to animals fed standard chow, rats exposed to the fc-HFHS diet exhibited increased body weight, liver weight, body fat and leptin in serum independently of saline or DHA maternal supplementation. Nevertheless, maternal DHA supplementation prevented both the glucose intolerance and the rise in serum insulin resulting from consumption of the fc-HFHS diet. In addition, animals from the DHA-fc-HFHS diet group showed decreased hepatic triglyceride accumulation compared to SAL-fc-HFHS rats. The beneficial effects on glucose homeostasis declined with age in male rats. Yet, the preventive action against hepatic steatosis was still present in 6-month-old animals of both sexes and was associated with decreased hepatic expression of lipogenic genes. The results of the present work show that maternal DHA supplementation during pregnancy programs a healthy phenotype into the offspring that was protective against the deleterious effects of an obesogenic diet.Keywords
Funding Information
- Agence Nationale de la Recherche (ANR-16-CE21-0007-01)
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación (2015-16-273510)
This publication has 80 references indexed in Scilit:
- Fish oil — How does it reduce plasma triglycerides?Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2012
- Changes in rat n-3 and n-6 fatty acid composition during pregnancy are associated with progesterone concentrations and hepatic FADS2 expressionProstaglandins, Leukotrienes and Essential Fatty Acids, 2012
- High Physiological Omega-3 Fatty Acid Supplementation Affects Muscle Fatty Acid Composition and Glucose and Insulin Homeostasis in Obese AdolescentsJournal of Nutrition and Metabolism, 2012
- Prenatal fatty acid status and child adiposity at age 3 y: results from a US pregnancy cohortThe American Journal of Clinical Nutrition, 2011
- Maternal Omega-3 Supplementation Increases Fat Mass in Male and Female Rat OffspringFrontiers in Genetics, 2011
- IUGR decreases PPARγ and SETD8 Expression in neonatal rat lung and these effects are ameliorated by maternal DHA supplementationEarly Human Development, 2010
- Liver fat and lipid oxidation in humansLiver International, 2009
- Glycine and urea kinetics in nonalcoholic steatohepatitis in human: effect of intralipid infusionAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2009
- Maternal and child undernutrition: consequences for adult health and human capitalThe Lancet, 2008
- Gestational hyperlipidemia in the rat is characterized by accumulation of n − 6 and n − 3 fatty acids, especially docosahexaenoic acidBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992